Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: OnKure Therapeutics Inc., 2 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
OnKure Therapeutics Inc. June 3, 202699.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 12, 2025 | Edgewise Therapeutics Inc. | Option exercise | +5,781 | — | — |
| Aug 12, 2025 | Edgewise Therapeutics Inc. | Open-market sale | −1,428 | $13.39 | $19,121 |
| May 2, 2025 | Edgewise Therapeutics Inc. | Open-market sale | −1,314 | $16.45 | $21,615 |
| May 1, 2025 | Edgewise Therapeutics Inc. | Option exercise | +5,209 | — | — |
| Oct 11, 2024 | Edgewise Therapeutics Inc. | Option exercise | +70,000 | $0.71 | $49,700 |
| Oct 4, 2024 | OnKure Therapeutics Inc. | Grant or award | +874 | — | — |
| Oct 4, 2024 | OnKure Therapeutics Inc. | Grant or award | +4,065 | — | — |
Questions about R. Michael Carruthers
What boards is R. Michael Carruthers on?
R. Michael Carruthers sits on the board of OnKure Therapeutics Inc.
How long has R. Michael Carruthers served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.